Abstract No. 127 Radioembolization for Hepatocellular Carcinoma with Localized Portal Vein Tumor Thrombosis in Patients with Preserved Liver Function

To evaluate the clinical outcomes of radioembolization and the impact of dosimetry for hepatocellular carcinoma (HCC) with localized portal vein tumor thrombosis (PVTT) in patients with preserved liver function

To evaluate the clinical outcomes of radioembolization and the impact of dosimetry for hepatocellular carcinoma (HCC) with localized portal vein tumor thrombosis (PVTT) in patients with preserved liver function